References
- Ballet S, Mauborgne A, Bourgoin S, Poliénor H, Farré A, Cesselin F, Hamon M. Effects of the novel analgesic, cizolirtine, on the spinal release of substance P and CGRP: in vitro and in vivo studies. Neuropharmacol 2001;40:578–89
- Alvarez I, Andreu F, Buxens J, Colombo M, Dordal A, Fort M, Gutiérrez B, Ferré A. Pharmacology of cizolirtine: a new anal-gesic agent. Methods Find Exp Clin Pharmacol 2000;22(4):211–21
- Hylden JL, Thomas DA, Iadorola MJ, Nahin RL, Dubner R. Spinal opioid analgesic effects are enhanced in a model of uni-lateral inflammation/hyperalgesia: possible involvement of noradrenergic mechanisms. Eur J Pharmacol 1991;194 (2–3):135–43
- Song HK, Pan HL, Eisenach JC. Spinal nitric oxide mediates antinociception from i.v. morphine. Anaesthesiol 1998;89:215–21
- Rogers DT, Iwamoto ET. Multiple spinal mediators in parenteral nicotine-induced antinociception. J Pharmacol Exp Ther 1993;267(1):341–9
- Christensen D, Idanpaan-Heikkila JJ, Guilbaud G, Kayser V. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA 966 in a rat model of peripheral neuropathy. Br J Pharmacol 1998;125(8):1641–50
- Matthew IR, Ogden GR, Frame JW, Wight AJ. Dose response and safety of cizolirtine citrate (E-4018) in patients with pain following extraction of third molars. Curr Med Res Opin 2000;16:107–14
- Melzac R. The McGill pain questionnaire: major properties and scoring methods. Pain 1975;1:277–99
- Beck AT and Beck RW. Screening depressed patients in family practice: a rapid technique. Postgrad Med 1972;52:81–5
- Parkhouse N, Crowe R, McGrouther DA, Burnstock G. Painful hypertrophic scarring and neuropeptides. Lancet 1992;340:1410
- Anand P. Nerve growth factor regulates nociception in human health and disease. Br J Anaesth 1995;75:201–8
- Cao YQ, Mantyh PW, Carlson EJ, Gillespie A, Epstein CJ, Basbaum AI. Primary afferent tachykinins are required to experience moderate to intense pain. Nature [Letters] 1998;392:390–94
- Mansikka H, Shiotani M, Winchurch R, Raja S. Neurokinin-1 receptors are involved in behavioral responses to high intensity heat stimuli and capsaicin-induced hyperalgesia in mice. Anesthesiol 1999;90:1643–9
- Doyle CA, Hunt SP. Substance P receptor (neurokinin-1)-expressing neurons in lamina I of the spinal cord encode for the intensity of noxious stimulation: a c-Fos study in rat. Neurosci 1999;89:17–28
- De Felipe C, Herrero JF, O’Brien JA, Palmer JA, Doyle CA, Smith AJH, Laird JMA, Belmonte C, Cervero F, Hunt SP. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature [Letters] 1998;392:394–7
- Abbadie C, Brown JL, Mantyh PW, Basbaum AI. Spinal cord substance P receptor immunoreactivity increases in both inflammatory and nerve injury models of persistent pain. Neurosci 1996;70:201–9
- Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999;353:1959–64
- Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999;83:389–400
- Attal N, Brasseur L, Parker F, Chauvin M, Bouhassira D. Effects of gabapentin on the different components of peripheral and central neuropathic pain syndromes: a pilot study. Eur Neurol 1998;40:191–200
- Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, LaMoreaux L, Garofalo E. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus – a randomized controlled trial. JAMA 1998;280:1831–6
- Rowbotham M, Harden N, Stacey B, Bernstein P, Miller LM. Gabapentin for the treatment of postherpetic neuralgia – a randomized controlled trial. JAMA 1998;280:1837–42
- Max MB, Byas-Smith MG, Gracely RH, Bennet GJ. Intravenous infusion of the NMDA antagonist, ketamine, in chronic posttraumatic pain with allodynia: a double-blind comparison to alfenatil and placebo. Clin Neuropharmacol 1995;18:360–68
- Warncke T, Stubhaug A, Jorum E. Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, crossover comparison with morphine and placebo. Pain 1997;72:99–106
- Sindrup SH, Andersen G, Madsen C, Smith T, Brosen K, Jensen TS. Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double blind, controlled trial. Pain 1999;83:85–90
- Baranowski AP, De Courcey J, Bonello E. A trial of intravenous lidocaine on the pain and allodynia of postherpetic neuralgia. J Pain Symp Man 1999;17:429–33